Published in Lancet on January 07, 1978
Reduction of acetylcholine sensitivity of chick muscle in culture by myasthenia gravis serum. Clin Exp Immunol (1978) 0.77
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Acetylcholine receptor and myasthenia gravis. Ann N Y Acad Sci (1976) 1.54
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis. Clin Exp Immunol (1977) 1.23
A monoclonal anti-idiotypic antibody against anti-receptor antibodies from myasthenic sera. Eur J Immunol (1982) 1.02
Antibodies from myasthenic patients that compete with cholinergic agents for binding to nicotinic receptors. Proc Natl Acad Sci U S A (1980) 0.96
Experimental myasthenia in Balb/c mice immunized with rat acetylcholine receptor from rat denervated muscle. Proc Natl Acad Sci U S A (1976) 0.96
Properties and serum levels of specific populations of anti-acetylcholine receptor antibodies in myasthenia gravis. Ann N Y Acad Sci (1981) 0.93
Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol (1978) 0.91
Monoclonal antibodies directed against the neurotransmitter binding site of nicotinic acetylcholine receptor. FEBS Lett (1980) 0.89
Antibodies to acetylcholine receptor in patients with thymoma but without myasthenia gravis. Neurology (1980) 0.84
Binding properties and subclass distribution of anti-acetylcholine receptor antibodies in myasthenia gravis. J Neuroimmunol (1981) 0.83
Study of two different subpopulations of anti-acetylcholine receptor antibodies in a rabbit with experimental auto-immune myasthenia gravis. Eur J Immunol (1977) 0.83
Central nervous-system involvement in experimental autoimmune myasthenia gravis. Lancet (1977) 0.83
[Antibodies against nicotine-like acetylcholine receptors of central nervous system and muscles in epileptics with IgA deficiency]. Schweiz Med Wochenschr (1978) 0.83
Specific binding to isolated acetylcholine receptor of a synthetic peptide duplicating the sequence of the presumed active center of a lethal toxin from snake venom. J Biol Chem (1982) 0.81
Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF. Eur Neurol (1983) 0.81
Purification and chemical characterization of melittin and acetylated derivatives. Biochim Biophys Acta (1980) 0.80
Accessibility to antibodies of acetylcholine receptors in the neuromuscular junction. Clin Exp Immunol (1976) 0.79
Cerebral coenurosis. Report of a case with arteritis. J Neurol (1977) 0.79
Interactions of acetylcholine receptor and acetylcholinesterase with lipid monolayers. Biochim Biophys Acta (1978) 0.78
[Contribution of Doppler's double ultrasonography to the diagnosis of brain death]. Schweiz Med Wochenschr (1974) 0.78
Purification from bee venom of melittin devoid of phospholipase A2 contamination. Anal Biochem (1982) 0.78
Characterization of iodinated derivatives of alpha-bungarotoxin. Hoppe Seylers Z Physiol Chem (1980) 0.77
Receptor-like activity of a monoclonal anti-idiotypic antibody against an anti-acetylcholine receptor antibody. Scand J Immunol (1984) 0.77
A nephropathy in the genesis of S.M.O.N.? Lancet (1973) 0.77
Reconstitution of pure acetylcholine receptor in phospholipid vesicles and comparison with receptor-rich membranes by the use of a potentiometric dye. J Membr Biol (1983) 0.76
[Involvement of the nervous system in infectious mononucleosis]. Rev Med Suisse Romande (1972) 0.75
[Myasthenia gravis: pathogenesis]. Rev Med Suisse Romande (1979) 0.75
Inactivation and solubilization of opiate receptors by phospholipases A2. Biochim Biophys Acta (1982) 0.75
[Plasma concentration of phenytoin in epileptics--importance for the clinician]. Schweiz Med Wochenschr (1975) 0.75
Monoclonal anti-torpedo receptor antibodies used to study antibody heterogeneity in myasthenic sera. Neurochem Int (1982) 0.75
[Clinical and biological evolution of myasthenia gravis after thymectomy in a 13-year-old girl]. Helv Paediatr Acta (1979) 0.75
[Nutritional neuropathies]. Ther Umsch (1970) 0.75
Antiacetylcholine receptor antibodies and myasthenia gravis. Int Rev Neurobiol (1983) 0.75
[Stabilized Hodgkin's lymphogranuloma and necrotizing encephalitis due to toxoplasmosis]. Schweiz Arch Neurol Neurochir Psychiatr (1972) 0.75
[Bilateral facial and trigeminal neuritis in the course of herpes simplex infection. 2 cases]. Schweiz Med Wochenschr (1974) 0.75
[The cerebro-spinal fluid in multiple sclerosis]. Rev Med Suisse Romande (1966) 0.75
[Value of echoencephalography for the diagnosis of cerebro-vascular diseases (author's transl)]. Schweiz Rundsch Med Prax (1975) 0.75
[Diabetic polyneuropathy and myelopathy caused by vitamin B12 deficiency]. Schweiz Arch Neurol Neurochir Psychiatr (1973) 0.75
[Infectious diseases: introduction]. Rev Med Suisse Romande (1972) 0.75
Antibodies against muscle and brain nicotinic acetylcholine receptors in IgA-deficient patients with epilepsy. Adv Cytopharmacol (1979) 0.75
[Vertebro-basilar insufficiencies]. Rev Med Suisse Romande (1970) 0.75
Recurrent familial neuropathy with liability to pressure palsies: reports of two cases and ultrastructural nerve study. J Neurol (1979) 0.75
A form of acute experimental autoimmune myasthenia gravis in mice occurring in absence of detectable circulating anti-acetylcholine receptor antibodies. Acute experimental myasthenia in mice. J Neurol Sci (1980) 0.75
[Ocular symptoms and manifestations in vitamin B12 deficiencies. Comments on bilateral optic neuropathies]. Ophthalmologica (1969) 0.75
Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor. J Neurol (1981) 0.75
The role of humoral immunity in myasthenia gravis. Prog Brain Res (1979) 0.75
[Therapies of myasthenia gravis (author's transl)]. Schweiz Rundsch Med Prax (1978) 0.75
[Consequeces of the elimination of a combination drug. Transition from combination antisacer: attention]. Schweiz Med Wochenschr (1977) 0.75
[Crural and lumbar plexus neuropathies under anticoagulant treatment]. Schweiz Med Wochenschr (1981) 0.75
Lack of cross-reactivity of a monoclonal antibody against the neurotransmitter site of Torpedo nicotinic acetylcholine receptor with muscle receptors from several sources. Mol Immunol (1983) 0.75
[Indications for plasmapheresis in myasthenia gravis ]. Ther Umsch (1982) 0.75
[Current clinical aspects of neuropathies due to vitamin B-12 deficiency]. Schweiz Med Wochenschr (1969) 0.75
[Usefulness of the immunoglobulin-albumin ratio compared to electrophoresis in the diagnosis of multiple sclerosis]. Schweiz Med Wochenschr (1978) 0.75
[Oculo-facio-cervical dystonia (progressive supranuclear palsy)]. Confin Neurol (1965) 0.75
The pathogenesis of myasthenia gravis. Bull Schweiz Akad Med Wiss (1978) 0.75
[The role of thymectomy in the treatment of myasthenia gravis]. Helv Chir Acta (1986) 0.75
[Paroxysmal headache upon changes of altitude in 2 cases of tumoral obstruction of holes of Monro]. Rev Otoneuroophtalmol (1970) 0.75
[Thymus and myasthenia]. Rev Med Suisse Romande (1973) 0.75
[Oculo-facio-cervical dystonia (progressive supranuclear palsy)]. Rev Neurol (Paris) (1965) 0.75
[Remarks on the relationship: cranio-cerebral injuries--multiple sclerosis]. Rev Otoneuroophtalmol (1969) 0.75
Evidence for sialic acid on the nicotinic acetylcholine receptor from Torpedo marmorata. Neurochem Int (1983) 0.75
[Herpesvirus meningoencephalitis]. Rev Med Suisse Romande (1970) 0.75
[Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)]. Ann Chir (1980) 0.75
[Evolution of viral diseases of the central nervous system]. Rev Med Suisse Romande (1975) 0.75
[Pathogenetics mechanisms of neuritides occurring in the course of viral infections (author's transl)]. Schweiz Rundsch Med Prax (1974) 0.75
[Myasthenia gravis: pathogenesis elucidated. Aetiology and relationship with thymus still unknown (author's transl)]. Schweiz Rundsch Med Prax (1977) 0.75
Immunological studies in thymectomized and non-thymectomized patients with myasthenia gravis. J Clin Lab Immunol (1978) 0.75
[Infraclinical-cerebral dysfunctions in the course of viral diseases]. Rev Med Suisse Romande (1972) 0.75
[Neurologic diseases caused by cytomegalovirus]. Schweiz Rundsch Med Prax (1982) 0.75